A Phase II Randomised Study of the Addition of Methotrexate 0.05 mg/kg 12 hourly for 8 doses to the Current Immunosuppressant Regimen for the Prevention of Liver Allograft Rejection

Update Il y a 4 ans
Reference: ISRCTN58758525

Extract

Not provided at time of registration


Inclusion criteria

  • Not Applicable: Liver allograf

Links